Position
Chief Medical Officer
Company
Gilead Sciences
Foster CityBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Gilead Sciences, Inc announced the appointment of Dietmar Berger, MD, PhD, as the Chief Medical Officer. Dr Berger will join the company on January 2, 2025, and will become a member of Gilead’s senior leadership team. He succeeds Merdad Parsey, MD, PhD.
Quick answer
Gilead Sciences Appoints Dietmar Berger as Chief Medical Officer (December 12, 2024). Gilead Sciences is based in Foster City, California, United States.
- Who is the new Chief Medical Officer at Gilead Sciences?
- Gilead Sciences named Dietmar Berger Chief Medical Officer, announced December 12, 2024.
- What did Gilead Sciences announce on December 12, 2024?
- Gilead Sciences, Inc announced the appointment of Dietmar Berger, MD, PhD, as the Chief Medical Officer. Dr Berger will join the company on January 2, 2025, and will become a member of Gilead’s senior leadership team.
- What does Gilead Sciences do?
- Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
- Where is Gilead Sciences based?
- Gilead Sciences is based in Foster City, California, United States.
- Which similar companies made leadership changes around the same time?
- TORL BioTherapeutics (December 2, 2024), BerGenBio ASA (November 20, 2024), Byondis B.V (November 19, 2024) and NRx Pharmaceuticals (November 18, 2024) also announced leadership changes within 45 days of Gilead Sciences.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- Byondis Appoints Louis Denis, M.D. as Chief Medical Officer (November 19, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
Who to call at Gilead Sciences, and when
A new leader at Gilead Sciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gilead Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gilead Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gilead Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.